Compare Abeona Therapeutics Inc (ABEO) vs Vanguard Sht-Term Inflation-Protected Sec Idx ETF (VTIP) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Abeona Therapeutics Inc vs Vanguard Sht-Term Inflation-Protected Sec Idx ETF — how do they compare? Abeona Therapeutics Inc trades at $6.79 (market cap $373.32M), while Vanguard Sht-Term Inflation-Protected Sec Idx ETF trades at $49.64. The key difference: Abeona Therapeutics Inc is trading nearer its 52-week high, Vanguard Sht-Term Inflation-Protected Sec Idx ETF nearer its low. Which is the better fit depends on your goals.
| ABEO | VTIP | |
|---|---|---|
Market Cap | $373.32M | — |
Sector | Health | — |
52-Week High | $7.23 | $50.75 |
52-Week Low | $4.17 | $49.39 |
Enterprise Value | $228.22M | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ABEO trades at $6.31, down 1.41% today, with a bullish technical outlook supported by moving averages. The company reported Q1 2026 results with revenue growth and beat EPS expectations, while maintaining strong profitability margins. Recent news highlights expansion of treatment centers and new cell therapy licensing.
Outlook remains positive with analyst consensus favoring Buy ratings (66.67%), though high RSI indicates potential near-term overbought conditions. Key risks include negative operating cash flow and reliance on new treatment adoption. Upside depends on continued commercial execution and pipeline advancements.
VTIP (Vanguard Short-Term Inflation-Protected Securities ETF) trades at $49.64 with minimal daily movement (+0.12%). The technical picture shows conflicting signals with moving averages indicating bearish pressure while oscillators suggest potential oversold conditions. Recent news highlights VTIP's role as an inflation hedge, with multiple institutional investors increasing positions. The ETF focuses on short-term Treasury Inflation-Protected Securities, designed to protect against rising consumer prices.
VTIP offers investors exposure to inflation-protected government bonds with lower duration risk than longer-term TIPS funds. Current market conditions favor inflation-hedging assets, though the fund faces risks from potential Fed policy shifts and interest rate volatility. The ETF's structure provides built-in CPI adjustment, making it relevant in the current inflationary environment.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Abeona Therapeutics Inc
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →About Vanguard Sht-Term Inflation-Protected Sec Idx ETF
The index is a market-capitalization-weighted index that includes all inflation-protected public obligations issued by the US Treasury with remaining maturities of less than 5 years. The advisor attempts to replicate the target index by investing all, or substantially all, of its assets in the securities that make up the index, holding each security in approximately the same proportion as its weighting in the index.
Read more on VTIP →
